扫码关注公众号           扫码咨询技术支持           扫码咨询技术服务
  
客服热线:400-901-9800  客服QQ:4009019800  技术答疑  技术支持  质量反馈  人才招聘  关于我们  联系我们
产品中心-北京博奥森生物技术有限公司
首页 > 产品中心 > 常用试剂 > 产品信息
Cell Counting Kit-8 (BA00208)  
订购热线:400-901-9800
订购邮箱:sales@bioss.com.cn
订购QQ:  400-901-9800
技术支持:techsupport@bioss.com.cn
说明书: 下载
100T/79.00元
500T/350.00元
10×500T/2900.00元
大包装/询价

产品编号 BA00208
英文名称 Cell Counting Kit-8
中文名称 细胞增殖及毒性检测试剂盒
别    名 Cell Counting Kit-8 (CCK-8); CCK-8; WST-8; Enhanced Cell Counting Kit-8; CCK-8 Cell Proliferation and Cytotoxicity Assay Kit; CCK-8 WST-8; Cell Counting Kit - 8;   CCK-8细胞增殖及毒性检测试剂盒; CCK8试剂盒; CCK-8/WST-8试剂盒; CCK-8细胞活力检测试剂盒; 细胞计数试剂盒-8(CCK-8); CCK-8试剂盒(细胞增殖及毒性检测试剂盒); Cell Counting Kit-8(CCK-8试剂盒); 细胞计数试剂盒-8; Cell Counting Kit-8(CCK-8)细胞活性检测试剂盒; 细胞活性检测试剂盒;
Specific References  (99)     |     BA00208 has been referenced in 99 publications.
[IF=17.694] Hu, Jinyuan. et al. Design of synthetic collagens that assemble into supramolecular banded fibers as a functional biomaterial testbed. NAT COMMUN. 2022 Nov;13(1):1-13  
[IF=10.75] Liu, Zhenni. et al. CD73/NT5E-mediated ubiquitination of AURKA regulates alcohol-related liver fibrosis via modulating hepatic stellate cell senescence. INT J BIOL SCI. 2023 Jan;19(3):950-966  
[IF=10.684] Peng Luo. et al. OP3-4 peptide sustained-release hydrogel inhibits osteoclast formation and promotes vascularization to promote bone regeneration in a rat femoral defect model. BIOENG TRANSL MED. 2022 Oct;:e10414  Other ;  Other.  
[IF=9.685] Yang, Wenjing. et al. BTN3A1 promotes tumor progression and radiation resistance in esophageal squamous cell carcinoma by regulating ULK1-mediated autophagy. CELL DEATH DIS. 2022 Nov;13(11):1-17  
[IF=9.417] Zhenjia Che. et al. Bifunctionalized hydrogels promote angiogenesis and osseointegration at the interface of three-dimensionally printed porous titanium scaffolds. MATER DESIGN. 2022 Nov;223:111118  Other ;  Other.  
[IF=9.229] Mengjia Wang. et al. Binding Peptide-Promoted Biofunctionalization of Graphene Paper with Hydroxyapatite for Stimulating Osteogenic Differentiation of Mesenchymal Stem Cells. Acs Appl Mater Inter. 2021;XXXX(XXX):XXX-XXX  
[IF=8.786] Junjun Guo. et al. TIGAR deficiency induces caspase-1-dependent trophoblasts pyroptosis through NLRP3-ASC inflammasome. FRONT IMMUNOL. 2023; 14: 1114620  
[IF=8.786] Xiaogang Shen. et al. Integrating machine learning and single-cell trajectories to analyze T-cell exhaustion to predict prognosis and immunotherapy in colon cancer patients. FRONT IMMUNOL. 2023; 14: 1162843  
[IF=8.025] Gaofeng Cai. et al. Structure of a Pueraria root polysaccharide and its immunoregulatory activity on T and B lymphocytes, macrophages, and immunosuppressive mice. INT J BIOL MACROMOL. 2023 Jan;:123386  
[IF=8.013] Yuchen Liu. et al. Docosahexaenoic Acid Attenuates Radiation-Induced Myocardial Fibrosis by Inhibiting the p38/ET-1 Pathway in Cardiomyocytes. INT J RADIAT ONCOL. 2022 Dec;:  
[IF=7.666] Shulipan Mulati. et al. 6-Shogaol Exhibits a Promoting Effect with Tax via Binding HSP60 in Non-Small-Cell Lung Cancer. CELLS-BASEL. 2022 Jan;11(22):3678  
[IF=7.419] Li-Ping Yu. et al. In vivo identification of the pharmacodynamic ingredients of Polygonum cuspidatum for remedying the mitochondria to alleviate metabolic dysfunction–associated fatty liver disease. BIOMED PHARMACOTHER. 2022 Dec;156:113849  Other ;  Other.  
[IF=7.397] Shunjie Yu. et al. TIM3/CEACAM1 pathway involves in myeloid-derived suppressor cells induced CD8+ T cells exhaustion and bone marrow inflammatory microenvironment in myelodysplastic syndrome. IMMUNOLOGY. 2022 May 03  
[IF=7.109] Zhao, Renchang. et al. Circular RNA circTRPS1-2 inhibits the proliferation and migration of esophageal squamous cell carcinoma by reducing the production of ribosomes. CELL DEATH DISCOV. 2023 Jan;9(1):1-10  
[IF=6.656] Gaofeng Cai. et al. The secretion of sIgA and dendritic cells activation in the intestinal of cyclophosphamide-induced immunosuppressed mice are regulated by Alhagi honey polysaccharides. PHYTOMEDICINE. 2022 Aug;103:154232  
[IF=6.656] Zhenwei Zhou. et al. BuShen JianGu Fang alleviates cartilage degeneration via regulating multiple genes and signaling pathways to activate NF-κB/Sox9 axis. PHYTOMEDICINE. 2023 May;113:154742  
[IF=6.58] Luqin Wan. et al. The advanced glycation end-products (AGEs)/ROS/NLRP3 inflammasome axis contributes to delayed diabetic corneal wound healing and nerve regeneration. Int J Biol Sci. 2022; 18(2): 809–825  Other ;  Other.  
[IF=6.53] Shilei Zhang. et al. A novel PHD2 inhibitor acteoside from Cistanche tubulosa induces skeletal muscle mitophagy to improve cancer-related fatigue. BIOMED PHARMACOTHER. 2022 Jun;150:113004  Other ;  Other.  
[IF=6.53] Xing-Hua Xiao. et al. Magnolol alleviates hypoxia-induced pulmonary vascular remodeling through inhibition of phenotypic transformation in pulmonary arterial smooth muscle cells. BIOMED PHARMACOTHER. 2022 Jun;150:113060  
[IF=6.529] Huifeng Wang. et al. Periplocin ameliorates mouse age-related meibomian gland dysfunction through up-regulation of Na/K-ATPase via SRC pathway. Biomed Pharmacother. 2022 Feb;146:112487  
[IF=6.388] Weiyi Zhang. et al. Cinnamaldehyde induces apoptosis and enhances anti-colorectal cancer activity via covalent binding to HSPD1. PHYTOTHER RES. 2023 Apr;:  
[IF=6.306] Yu Han. et al. Structural characterization and transcript-metabolite correlation network of immunostimulatory effects of sulfated polysaccharides from green alga Ulva pertusa. Food Chem. 2021 Apr;342:128537  
[IF=6.289] Zhengqing Zhu. et al. Three-dimensionally printed porous biomimetic composite for sustained release of recombinant human bone morphogenetic protein 9 to promote osteointegration. Mater Design. 2021 Oct;208:109882  Other ;  
[IF=6.208] Lan Wang. et al. Fenbendazole Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice via Suppression of Fibroblast-to-Myofibroblast Differentiation. INT J MOL SCI. 2022 Jan;23(22):14088  
[IF=6.117] Xiaoshan Liang. et al. Folic Acid Ameliorates Synaptic Impairment following Cerebral Ischemia/Reperfusion Injury via Inhibiting Excessive Activation of NMDA Receptors. J NUTR BIOCHEM. 2022 Nov;:109209  
[IF=6.081] Min Yu. et al. RIOK2 Inhibitor NSC139021 Exerts Anti-Tumor Effects on Glioblastoma via Inducing Skp2-Mediated Cell Cycle Arrest and Apoptosis. Biomedicines. 2021 Sep;9(9):1244  Other ;  mouse.  
[IF=6.081] Qianyu Cheng. et al. Establishing and characterizing human stem cells from the apical papilla immortalized by hTERT gene transfer. FRONT CELL DEV BIOL. 2023; 11: 1158936  
[IF=6.023] Huan Liu. et al. Effect of DEHP and DnOP on mitochondrial damage and related pathways of Nrf2 and SIRT1/PGC-1α in HepG2 cells. Food Chem Toxicol. 2021 Dec;158:112696  CCK8 ;  
[IF=5.923] Jiali Xiong. et al. Rno_circ_0001004 Acts as a miR-709 Molecular Sponge to Regulate the Growth Hormone Synthesis and Cell Proliferation. Int J Mol Sci. 2022 Jan;23(3):1413  Other ;  Other.  
[IF=5.846] Mengqi Gu. et al. Influence of placental exosomes from early onset preeclampsia women umbilical cord plasma on human umbilical vein endothelial cells. FRONT CARDIOVASC MED. 2022 Dec 23;9:1061340  
保存条件 Protect from light. Store at 2-8℃ for one year. Store at -20℃ for two year.
注意事项 This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
产品介绍 Cell Counting Kit-8,即增强型 CCK-8 试剂盒,是一种基于 WST-8 而广泛应用于细胞增殖和细胞毒性的快速、高灵敏度、无放射性的比色检测试剂盒。WST-8 在电子耦合试剂存在的情况下,可以被线粒体内的一些脱氢酶还原生成橙黄色的 formazan,且细胞增殖越多越快,则颜色越深;细胞毒性越大,则颜色越浅。对于同样的细胞,颜色的深浅 (生成的 formazan 量) 和细胞数目呈线性关系。

WST-8 是 MTT 的一种升级替代产品,和 MTT 或其它 MTT 类似产品,如 XTT、MTS 等相比有明显的优点。第一,MTT 被线粒体内的一些脱氢酶还原生成的 formazan 不是水溶性的,需要有特定的溶剂来溶解;而 WST-8 和 XTT、MTS 产生的 formazan 都是水溶性的,可以省去后续的溶解步骤。第二,WST-8 产生的 formazan 比 XTT 和 MTS 产生的 formazan 更易溶解。第三,WST-8 比 XTT 和 MTS更加稳定,使实验结果更可靠。第四,WST-8 和 MTT、XTT 等相比线性范围更宽,灵敏度更高,并且更加稳定。

WST-8 对细胞无明显毒性,可以直接加入到细胞样品中,无需预配各种成分;显色后,可以在不同时间反复用酶标仪读板,检测时间更加灵活,便于确定最佳测定时间;酚红和血清对本试剂盒的测定无明显影响。

产品图片
Bioss CCK-8产品(BA00208)与国际G品牌对比图:图中左侧样本为SP2/O的检测数据,右侧样本为3T3的检测数据.Bioss产品稳定性与特异性与国际G品牌同等优质.
Bioss CCK-8产品(BA00208)与国际D品牌对比图:图中左侧样本为SP2/O的检测数据,右侧样本为3T3的检测数据.Bioss产品稳定性与特异性与国际D品牌同等优质.
版权所有 2004-2026 www.bioss.com.cn 北京博奥森生物技术有限公司
通过国际质量管理体系ISO 9001:2015 GB/T 19001-2016    证书编号: 00124Q34771R2M/1100
通过国际医疗器械-质量管理体系ISO 13485:2016 GB/T 42061-2022    证书编号: CQC24QY10047R0M/1100
京ICP备05066980号-1         京公网安备110107000727号